Benjamin Edwards’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Benjamin Edwards's ALNY Position: Q3 2026 in Review
Benjamin Edwards increased its Alnylam Pharmaceuticals (ALNY) stake by 5.7% in Q3 2026, buying an estimated $17K and bringing the position to 1,235 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.
Benjamin Edwards first reported a position in ALNY in Q3 2025 and has held it in 5 quarters since. The position peaked at $359K in Q1 2026. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Benjamin Edwards held 1,235 shares of Alnylam Pharmaceuticals worth $305K as of Q3 2026.
- Benjamin Edwards bought 67 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $17K.
- Alnylam Pharmaceuticals made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1252 holding.
- Benjamin Edwards first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Benjamin Edwards's Alnylam Pharmaceuticals position peaked at $359K in Q1 2026.
- 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.